India, Dec. 18 -- In today's fast-evolving pharmaceutical landscape, collaboration is now the new competitive advantage. Imagine a world where patients can gain access to lifesaving drugs in months, not years; this is no longer some endpoint but an ongoing reality powered by strategic partnerships that are rewriting the way the global pharma industry innovates, scales, and delivers. The driving force for speed, innovation, and resilience in drug manufacturing is no longer competition but collaboration.

The global pharmaceutical market today has crossed the $1.5 trillion mark, driven by an increasing number of partnerships between large pharmaceutical players, biotech innovators, and technology disrupters. A Pfizer-BioNTech alliance durin...